Morpheus8 Subdermal Adipose Remodeling & Fractional RF
Clinical Treatment Summary: Morpheus8 is a minimally invasive subdermal adipose remodeling (SARM) platform combining insulated microneedling with fractional radiofrequency (RF). Administered under the surgical expertise of Prof. Dr. Ismail Kucuker at our Istanbul clinic (Bagdat Avenue), the system penetrates to precise depths of up to 4 mm on the face and 7–8 mm on the body. This targeted thermal coagulation remodels deep fibroseptal networks, contracts subdermal fat, and initiates extensive neocollagenesis. Thanks to its "color-blind" RF architecture, it treats all Fitzpatrick skin types (I–VI) with minimal post-procedure downtime.
Morpheus8 provides deep structural contouring by addressing both the reticular dermis and the underlying fibroseptal network.
Traditional non-invasive tightening often falls short when soft tissue redundancy stems from laxity in deeper structural bands. Morpheus8 bridges this gap through subdermal adipose remodeling (SARM).
Plastic, Reconstructive, and Aesthetic Surgery Specialist Prof. Dr. Ismail Kucuker customizes microneedle penetration depths and RF thermal vectors at our Istanbul clinic, delivering targeted contraction to sagging facial and body tissues.

Anatomical Areas Treated with Morpheus8
With interchangeable specialized tip configurations (Morpheus8 Face, Morpheus8 Body, and Prime), the system treats multiple clinical indications across the face and body:
Biological Action: Subdermal Adipose Remodeling (SARM)
The mechanism of Morpheus8 centers on fractional bipolar radiofrequency delivered via gold-plated medical microneedles. Because the needle shafts are insulated, thermal energy is discharged exclusively from the exposed tips into target tissue depths.
This localized electrothermal pulse heats subdermal fat to 65°C–70°C, causing selective adipocyte coagulation and shortening collagenous fibrous septa. Concurrently, wound healing cascades release cytokines and growth factors, initiating fresh neocollagenesis and neoelastogenesis that continue for several months.
Frequently Asked Questions About Morpheus8
Topical prescription numbing cream applied 30 to 45 minutes prior to the session manages procedure discomfort effectively. Patients generally report local pressure and a warm prickling sensation during treatment passes.
Most treatment protocols require 2 to 3 sessions scheduled 4 to 6 weeks apart. Initial skin smoothing is visible within 2 to 3 weeks, while ongoing collagen and elastin remodeling matures over 3 to 6 months.
Yes. Its color-blind radiofrequency technology bypasses superficial epidermal melanin, making it safe for all Fitzpatrick skin classifications (I through VI) without typical hyperpigmentation risks.
Mild erythema and transient micro-swelling typically resolve within 24 to 48 hours. Most patients can return to work the next day and resume light makeup application after 48 hours.